APA (7th ed.) Citation

Golumba‐Nagy, V., Yan, S., Steinbach‐Knödgen, E., Thiele, J., Esser, R. L., Haak, T. H., . . . Kofler, D. M. (2023). Treatment of rheumatoid arthritis with baricitinib or upadacitinib is associated with reduced scaffold protein NEDD9 levels in CD4+ T cells. Physiological Reports, 11(19), 1. https://doi.org/10.14814/phy2.15829

Chicago Style (17th ed.) Citation

Golumba‐Nagy, Viktoria, et al. "Treatment of Rheumatoid Arthritis with Baricitinib or Upadacitinib Is Associated with Reduced Scaffold Protein NEDD9 Levels in CD4+ T Cells." Physiological Reports 11, no. 19 (2023): 1. https://doi.org/10.14814/phy2.15829.

MLA (9th ed.) Citation

Golumba‐Nagy, Viktoria, et al. "Treatment of Rheumatoid Arthritis with Baricitinib or Upadacitinib Is Associated with Reduced Scaffold Protein NEDD9 Levels in CD4+ T Cells." Physiological Reports, vol. 11, no. 19, 2023, p. 1, https://doi.org/10.14814/phy2.15829.